Al-Marsad Journal: Researchers have found a solution for the so-called polypill, which combines three drugs needed to prevent cardiovascular problems.
In what appears to be the largest and longest controlled study of this approach, patients who were prescribed a polypill within six months of a heart attack were more likely to continue taking the drugs and had significantly fewer cardiovascular events, compared to those who received the combination The usual cereal.
Study participants did not report deaths from cardiovascular disease, although the overall risk of death from all causes did not change significantly.
The study of more than 2,000 heart patients, followed for three years, was published in the New England Journal of Medicine, where the results were presented at the Congress of the European Society of Cardiology in Barcelona.
Expert opinions
The study is the culmination of 15 years of work by researchers led by Dr. Valentin Foster, director of the Mount Sinai Heart Center at Mount Sinai Hospital in New York City and general manager of the National Center for Cardiovascular Research in Spain.
“It’s easier to take one pill than several, and it’s easier to take it once a day than several times a day,” says Dr. Thomas Wang, chief of internal medicine at UT Southwestern Medical Center, who was not involved. in research, but wrote an editorial accompanying the study ».
The availability of Polypill also appears to prompt doctors to write prescriptions more in line with practice guidelines, Dr. Wang added: “Under normal circumstances, doctors often prescribe drugs that should be given too little.”
Polypill combines a blood pressure drug, a cholesterol-lowering drug, and aspirin, which helps prevent blood clots.
The idea was first launched two decades ago in a more radical form and proponents of this approach have suggested giving the daily multipill to everyone once they reach 55, claiming it would reduce cardiovascular events globally. 80%.
